GENETIC TESTING SUMMIT AGENDA
Eyes on the Prize: Truth Telling about Genetic Testing
Renaissance M Street, Washington, DC
Draft Agenda
Thursday, September 20, 2007
8 AM Registration/Continental breakfast
9 AM
DHHS & Personalized Health Care
Greg Downing, Program Director, Personalized Health Care,
U.S. Department of Health and Human Services (HHS)
9:15 AM
Truth Telling about Genetic Testing
Sharon Terry, President and CEO, Genetic Alliance
9:30 AM
Survey of the Characteristics of a Range of Tests
Howard McLeod, Director, University of North Carolina (UNC)
Institute for Pharmacogenomics and Individualized Therapy
10:00 AM Q & A
10:30 AM Break
11:00 AM
Research and Development Opportunities and Challenges
Francis Collins, Director, National Human Genome Research Institute
Brad Popovich, President and CEO, Sirius Genomics
Randy Scott, Chairman and CEO, Genomic Health
11:45 AM Q & A
12:15 PM Summary of the morning
Sharon Terry, President and CEO, Genetic Alliance
12:30 PM Lunch
1:30 PM
Translation and Test Development
Moderated by
Christopher Austin, Director, NIH Chemical Genomics
Center
- ANALYTICAL VALIDITY, CLINICAL VALIDITY, CLINICAL UTILITY
Linda Bradley, Evaluation of Genomic Applications in Practice and
Prevention, Geneticist, National Office of Public Health Genomics, CDC
- CLINICAL SIGNIFICANCE: SO YOU CAN DO IT, DOES IT MATTER?
Elda Railey, Co-founder, Research Advocacy Network
- CHALLENGES IN APPLYING GENOMIC TECHNOLOGY TO
MOLECULAR DIAGNOSTICS
Janet A. Warrington, Vice President, Standards and Government
Policy, Affymetrix
2:15 PM Q & A
3:00 PM Break
3:30 PM
Clinical Delivery/Commercialization Roundtable
Moderated by
Robert Egge, Executive Director of the Alzheimer
